Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
1 hedge funds and large institutions have $2.2K invested in Calithera Biosciences, Inc in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
44% less capital invested
Capital invested by funds: $3.92K → $2.2K (-$1.72K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAS
Coppell Advisory Solutions
Coppell,
Texas
|
+$2.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCA
FinTrust Capital Advisors
Greenville,
South Carolina
|
-$3.92K |
CALA Hedge Fund Activity: Q3 2023 in Review
1 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q3 2023, worth a combined $2.2K — down 44% from $3.92K a quarter earlier.
Fund positioning in CALA was balanced in Q3 2023: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was Coppell Advisory Solutions, opening a new position worth an estimated $2.2K. The largest seller was FinTrust Capital Advisors, exiting entirely with an estimated $3.92K sold.
- 1 institutional investor held Calithera Biosciences, Inc (CALA) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $2.2K of Calithera Biosciences, Inc stock for Q3 2023, down 44% quarter-over-quarter.
- 1 fund opened new Calithera Biosciences, Inc positions in Q3 2023 and 1 closed out, a net change of 0 holders.
- The largest Calithera Biosciences, Inc buyer in Q3 2023 was Coppell Advisory Solutions, an estimated $2.2K added.
- The largest Calithera Biosciences, Inc seller in Q3 2023 was FinTrust Capital Advisors, an estimated $3.92K sold.
Based on aggregated 13F filings for Q3 2023.